BSX NYSE
Boston Scientific Corporation
1W: +6.7%
1M: -11.9%
3M: -23.4%
YTD: -39.7%
1Y: -46.4%
3Y: +6.3%
5Y: +37.5%
$57.78
+0.63 (+1.10%)
Weekly Expected Move ±7.1%
$45
$49
$53
$56
$60
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.63
Bullish
8 bullish
1 neutral
1 bearish
Articles (7d)
10
Daily Sentiment (7 Days)
Articles (100)
Why Is Boston Scientific (BSX) Down 13% Since Last Earnings Report?
ISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver?
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum
Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?
Company News for May 19, 2026
Boston Scientific’s SEISMIQ 4CE succeeds in trial for coronary artery disease
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal
Boston Scientific Bets on Growth Through Strategic M&A Deals
Here's How Boston Scientific Is Expanding Its Global Growth
Should You Buy, Hold or Sell BSX Stock Amid Cardiovascular Boom?
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?
SNN vs. BSX: Which Stock Is the Better Value Option?
DEADLINE ALERT for BSX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
3 Growth Stocks the Market Is Throwing Away and Why You Should Pick Them Up
BSX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
Notable healthcare headlines for the week: Merck, Eli Lilly, and GE HealthCare in focus
Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It?
S&P 500 surges over 10% in April; Detrick says history favors more gains
Polen Global Growth adds META, ASML; exits ABT, ADBE among Q1 moves
BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know
BSX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
J&J Sees Continued MedTech Improvement in Q1, Eyes Better 2026
Joby Aviation Is 'Too Risky,' But This Industrial Stock Is A 'Winner': Jim Cramer
Comerica Bank Has $25.22 Million Stock Holdings in Boston Scientific Corporation $BSX
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Weak U.S. Electrophysiology Sales and Misstated 2026 Outlook: Levi & Korsinsky
BSX DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
Calamos Wealth Management LLC Cuts Stake in Boston Scientific Corporation $BSX
Boston Scientific Corporation $BSX Shares Sold by Calamos Advisors LLC
Intuitive Surgical vs Boston Scientific: Which Stock Is the Better Buy Post Q1?
Arizona State Retirement System Reduces Stake in Boston Scientific Corporation $BSX
BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Is Innovation-Led Growth Driving ISRG's Revenues Above Procedures?
Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings
GE Vernova To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday
Company News for Apr 23, 2026
Cwm LLC Has $3.49 Million Stock Holdings in Boston Scientific Corporation $BSX
BSX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations
Why Is Boston Scientific Stock Soaring Wednesday?
Nasdaq 100 Tops Records As Iran Ceasefire Extends, GE Vernova Soars 13%: Stock Market Today
BSX Q1 Earnings Match, '26 View Down, Stock Gains in Premarket
BSX Q1 Earnings Match, '26 View Down, Stock Gains in Premarket
BSX Q2 2025 Earnings Transcript
BSX Q3 2025 Earnings Transcript
BSX Q1 2026 Earnings Transcript
GE Vernova, Boston Scientific, Intuitive Surgical And Other Big Stocks Moving Higher On Wednesday
Boston Scientific (BSX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Boston Scientific Q1 2026 Earnings Call Transcript
Abbott is the most oversold healthcare stock as Q1 earnings roll on
Boston Scientific (BSX) Q1 Earnings Match Estimates
Earnings Scheduled For April 22, 2026
Boston Scientific cuts full-year outlook despite Q1 beat
Boston Scientific Non-GAAP EPS of $0.80 beats by $0.01, revenue of $5.2B beats by $30M
Boston Scientific announces results for first quarter 2026
CPC Advisors LLC Sells 27,747 Shares of Boston Scientific Corporation $BSX
Top Wall Street Forecasters Revamp Boston Scientific Expectations Ahead Of Q1 Earnings
2,652,522 Shares in Boston Scientific Corporation $BSX Bought by Alphinity Investment Management Pty Ltd
Here are the major earnings before the open Wednesday
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
Boston Scientific Stock Is Trending Today: What To Know Now
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Earnings week ahead: TSLA, IBM, T, INTC, GE, BA, UNH, NOW, PM, CMCSA, and more
Assetmark Inc. Has $10.15 Million Stock Holdings in Boston Scientific Corporation $BSX
Asset Management One Co. Ltd. Increases Stock Position in Boston Scientific Corporation $BSX
AE Wealth Management LLC Boosts Stake in Boston Scientific Corporation $BSX
Will Robust Cardiovascular Performance Fuel BSX's Q1 Earnings?
Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit — The Gross Law Firm
Intuitive Surgical Pre-Q1 Analysis: Buy, Hold or Sell the Stock Now?
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today
Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?
Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm
Boston Scientific (BSX) Stock Slides as Market Rises: Facts to Know Before You Trade
BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
BSX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
AK Global Asset Management LLC Acquires New Holdings in Boston Scientific Corporation $BSX
Boston Scientific (BSX) Stock Sinks As Market Gains: Here's Why
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Alleged Concealment of Electrophysiology Demand Weaknesses: Levi & Korsinsky
Boston Scientific Corporation $BSX Stake Lifted by Savvy Advisors Inc.
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Nike, Boston Scientific, And Sysco Are Among Top 10 Large Cap Losers Last Week (March 30-April 2): Are the Others in Your Portfolio?
Boston Scientific Corporation $BSX Holdings Cut by Arvest Investments Inc.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch